Projects funded by the NCN
Unveiling the molecular signature underlying resistance to CD19 CAR-T therapy in malignant cells.
2023/49/N/NZ7/03096
Keywords:
CAR-T cells CD19 resistance tumor cell therapy
Descriptors:
- NZ7_16: Other related subjects
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 22 - announced on 2023-03-16
Amount awarded: 210 000 PLN
Project start date (Y-m-d): 2024-01-17
Project end date (Y-m-d): 2027-01-16
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.